Avivagen continues expansion in Asia

Avivagen Inc, one of the leading providers of natural alternatives to antibiotics, has received a new purchase order for its OxC-beta Livestock product in Asia

Numerous international livestock trials with poultry and swine are using OxC-beta technology. (Image source: Brando Bean/Flickr)

Avivagen’s OxC-beta technology is a non-antibiotic means of maintaining optimal health and growth. OxC-beta Livestock is a proprietary product shown to be effective and economic in replacing the antibiotics commonly added to livestock feeds.

According to the company, numerous international livestock trials with poultry and swine using OxC-beta Livestock have proven that the product performs and in some aspects, better than in-feed antibiotics.

The technology is derived from Avivagen discoveries about carotenoids, compounds that give certain fruits and vegetables their bright colours.